梅花生物跌2.07%，成交额3.07亿元，主力资金净流出873.22万元

Core Viewpoint - MeiHua Bio's stock experienced a decline of 2.07% on November 21, with a trading price of 10.40 CNY per share and a total market capitalization of 29.164 billion CNY [1] Financial Performance - For the period from January to September 2025, MeiHua Bio reported a revenue of 18.215 billion CNY, representing a year-on-year decrease of 2.49%. However, the net profit attributable to shareholders increased by 51.61% to 3.025 billion CNY [2] Shareholder Information - As of September 30, 2025, the number of shareholders for MeiHua Bio reached 66,700, an increase of 13.10% from the previous period. The average number of circulating shares per shareholder decreased by 13.09% to 42,058 shares [2] Dividend Distribution - Since its A-share listing, MeiHua Bio has distributed a total of 12.047 billion CNY in dividends, with 4.075 billion CNY distributed over the past three years [3] Major Shareholders - As of September 30, 2025, Hong Kong Central Clearing Limited was the second-largest circulating shareholder, holding 98.9229 million shares, an increase of 18.3366 million shares from the previous period. New shareholders include Guotai CSI Livestock Breeding ETF and Southern S&P China A-share Large Cap Dividend Low Volatility 50 ETF [3]